Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Boehringer Ingelheim
Boehringer Ingelheim
Gilead Sciences
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
Eli Lilly and Company
Pfizer
Eli Lilly and Company
Hoffmann-La Roche
AstraZeneca
Merck Sharp & Dohme LLC
Arcus Biosciences, Inc.
Revolution Medicines, Inc.
Verastem, Inc.
AstraZeneca
Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Pfizer
Merck Sharp & Dohme LLC
BioNTech SE
Taiho Oncology, Inc.
Regeneron Pharmaceuticals
Eli Lilly and Company
AstraZeneca
Jiangsu HengRui Medicine Co., Ltd.
Lantern Pharma Inc.
BeiGene
Mirati Therapeutics Inc.
Prestige Biopharma Limited
Avistone Biotechnology Co., Ltd.
Bristol-Myers Squibb
Checkpoint Therapeutics, Inc.
EpicentRx, Inc.
Blueprint Medicines Corporation
Novartis
Samsung Bioepis Co., Ltd.
Actuate Therapeutics Inc.
BeiGene
NantCell, Inc.
EpicentRx, Inc.
Humanetics Corporation
Cantargia AB
Blueprint Medicines Corporation
Ionis Pharmaceuticals, Inc.
Spectrum Pharmaceuticals, Inc
BioNTech SE
CTI BioPharma
Mereo BioPharma
Celgene
Acrotech Biopharma Inc.